Evidence map›Paper›PMID 37907529›Full record

ArticleNPJ systems biology and applications2023

Data-driven structural analysis of small cell lung cancer transcription factor network suggests potential subtype regulators and transition pathways.

Mustafa Ozen, Carlos F Lopez

Open access · goldAbstract read
In one paragraph

Article in NPJ systems biology and applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Mustafa OzenDept. of Biochemistry, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0002-7708-6549
Carlos F LopezDept. of Biochemistry, Vanderbilt University, Nashville, TN, USA. clopez@altoslabs.com.ORCID 0000-0003-3668-7468
Hewlett-Packard (United States) · USVanderbilt University · US

Funding

Single-Cell Biology and Data Analysis Shared Resource (SCB-DA SR)U54CA217450 · NCI · VANDERBILT UNIVERSITY · PI WEAVER, ALISSA M · 2018 to 2022
$8.5M
Phenotype Transitions in Small Cell Lung CancerU01CA215845 · NCI · VANDERBILT UNIVERSITY · PI LOPEZ, CARLOS FEDERICO, QUARANTA, VITO · 2017 to 2021
$2.8M
NCI NIH HHS U01 CA215845NCI NIH HHS U54 CA217450
6 · The paper itself

Abstract

Small cell lung cancer (SCLC) is an aggressive disease and challenging to treat due to its mixture of transcriptional subtypes and subtype transitions. Transcription factor (TF) networks have been the focus of studies to identify SCLC subtype regulators via systems approaches. Yet, their structures, which can provide clues on subtype drivers and transitions, are barely investigated. Here, we analyze the structure of an SCLC TF network by using graph theory concepts and identify its structurally important components responsible for complex signal processing, called hubs. We show that the hubs of the network are regulators of different SCLC subtypes by analyzing first the unbiased network structure and then integrating RNA-seq data as weights assigned to each interaction. Data-driven analysis emphasizes MYC as a hub, consistent with recent reports. Furthermore, we hypothesize that the pathways connecting functionally distinct hubs may control subtype transitions and test this hypothesis via network simulations on a candidate pathway and observe subtype transition. Overall, structural analyses of complex networks can identify their functionally important components and pathways driving the network dynamics. Such analyses can be an initial step for generating hypotheses and can guide the discovery of target pathways whose perturbation may change the network dynamics phenotypically.

Indexed as

Lung NeoplasmsSmall Cell Lung CarcinomaGene Expression Regulation, NeoplasticHumansTranscription FactorsTranscription Factors

Identifiers

PMID37907529
PMCPMC10618210
OpenAlexW4388039291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.